Skip to main content
Market intelligence
INMHealthcare

InMed Pharmaceuticals Inc insider activity

In the last 90 days, 6 corporate insiders purchased $1,737,330 of stock on the open market.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$1,737,330
Corporate buyers
6
Latest transaction
Jul 16, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Jul 16, 2026Vivo Opportunity LlcCorporate insiderOpen Market Purchase20,546$1.55$31,846
Jul 16, 2026Vivo Opportunity Cayman Fund L.p.Corporate insiderOpen Market Purchase20,546$1.55$31,846
Jul 16, 2026Vivo Opportunity Cayman LlcCorporate insiderOpen Market Purchase20,546$1.55$31,846